NCT04885374Recruiting
China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine
Source: ClinicalTrials.gov · Last updated 13 May 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A multi-center registration study of clinical characteristics of amyotrophic lateral sclerosis (ALS) patients with traditional Chinese medicine (TCM).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 8 May 2021
- Start date
- 1 Mar 2021
- Primary completion date
- 1 May 2027
- Lead sponsor
- Dongzhimen Hospital, Beijing
- Diseases
- ALS (motor neurone disease)
- NCT number
- NCT04885374
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 1 Mar 2021 to the primary completion date, 1 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who refuse informed consent.
Who the study is looking for
- Patients aged 18 years and older.
- Patients with possible, laboratory supported probable, probable, or definite ALS according to the revised El Escorial criteria.
- ALS patients treated with traditional Chinese medicine.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dongzhimen Hospital, Beijing University of Chinese Medicine Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.